Boswellia Extract Grades Explained: 65% to 90% & AKBA 10–30%

First, Pick the Marker

Before comparing percentages, decide what your formulation is positioned on. If your label, dossier or marketing references total boswellic acids, you want a titration grade (65–90%). If it references AKBA — the specific 5-lipoxygenase inhibitor behind much of the clinical literature — you want an HPLC grade (10–30% AKBA). The two are measured differently and are not interchangeable; the titration vs HPLC guide explains why.

Total Boswellic Acid Grades (Titration)

65% — the workhorse

The standard commercial grade. It delivers a clinically meaningful boswellic-acid load at the best cost-in-use, which is why it anchors most everyday joint-health capsules and tablets. Our representative 65% batch assays at 75.58% by titration, comfortably above spec.

75% / 85% — concentrated

Higher concentration lets you hit the same daily boswellic-acid dose in fewer milligrams, reducing capsule count or freeing label space for co-actives. Suited to concentrated anti-inflammatory and premium joint formulas.

90% — maximum potency

The most concentrated total-acid grade, for low-pill-burden products and high-dose clinical formats where every milligram of filler counts.

AKBA Grades (HPLC)

10% / 20% AKBA

Marker-defined grades for products positioned on AKBA content. These align with branded clinical extracts and suit supplements that make AKBA-specific claims or follow an AKBA-based dosing rationale.

30% AKBA

The premium AKBA grade — the highest routinely available marker concentration, for clinical-dose, AKBA-led joint products where the AKBA figure is the headline.

Grade-to-Product Map

Cost, Dose and Pill Burden Trade-offs

Three levers move together when you pick a grade:

• Cost-in-use, not price-per-kg. A higher grade costs more per kilo but you use less of it per dose — compare on the cost to deliver your target boswellic-acid (or AKBA) load, not on headline kg price.
• Pill burden. Higher concentration means fewer or smaller capsules, which improves compliance and lets you add co-actives like curcumin without oversizing the dose.
• Claim alignment. Never pay for a 30% AKBA grade if your product claims total boswellic acids — and never claim AKBA off a titration grade that wasn't HPLC-tested for it.

For dosing targets and co-formulation, see the joint-health formulation guide. To confirm the grade you buy is genuine B. serrata and not cut with other species, see species & adulteration.